Selected research
Industry Growth & Trends
Global Edaravone Industry Growth and Trends Forecast to 2032
Market perspective
The global Edaravone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Edaravone include Mitsubishi Tanabe Pharma, Piramal Healthcare, Simcere, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., UCB India Ltd and Unichem Laboratories Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Edaravone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Edaravone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Edaravone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Edaravone.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Edaravone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Edaravone Market by Company
Mitsubishi Tanabe Pharma
Piramal Healthcare
Simcere
Sun Pharmaceutical Industries Ltd.
Taj Pharmaceuticals Ltd.
UCB India Ltd
Unichem Laboratories Ltd
Edaravone Segment by Type
Oral Edaravone
Injection Edaravone
Edaravone Segment by Application
Hospital
Clinic
Others
Edaravone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edaravone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Edaravone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edaravone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Edaravone
- Injection Edaravone
Applications
- Hospital
- Clinic
- Others
Companies covered
- Mitsubishi Tanabe Pharma
- Piramal Healthcare
- Simcere
- Sun Pharmaceutical Industries Ltd.
- Taj Pharmaceuticals Ltd.
- UCB India Ltd
- Unichem Laboratories Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Edaravone Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Edaravone Sales Estimates and Forecasts (2021-2032)
- 1.3 Edaravone Market by Type
- 1.3.1 Oral Edaravone
- 1.3.2 Injection Edaravone
- 1.4 Global Edaravone Market Size by Type
- 1.4.1 Global Edaravone Market Size Overview by Type (2021-2032)
- 1.4.2 Global Edaravone Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Edaravone Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Edaravone Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Edaravone Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Edaravone Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Edaravone Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Edaravone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Edaravone Industry Trends
- 2.2 Edaravone Industry Drivers
- 2.3 Edaravone Industry Opportunities and Challenges
- 2.4 Edaravone Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Edaravone Revenue (2021-2026)
- 3.2 Global Top Players by Edaravone Sales (2021-2026)
- 3.3 Global Top Players by Edaravone Price (2021-2026)
- 3.4 Global Edaravone Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Edaravone Major Company Production Sites & Headquarters
- 3.6 Global Edaravone Company, Product Type & Application
- 3.7 Global Edaravone Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Edaravone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Edaravone Players Market Share by Revenue in 2025
- 3.8.3 2025 Edaravone Tier 1, Tier 2, and Tier 3
4 Edaravone Regional Status and Outlook
- 4.1 Global Edaravone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Edaravone Historic Market Size by Region
- 4.2.1 Global Edaravone Sales in Volume by Region (2021-2026)
- 4.2.2 Global Edaravone Sales in Value by Region (2021-2026)
- 4.2.3 Global Edaravone Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Edaravone Forecasted Market Size by Region
- 4.3.1 Global Edaravone Sales in Volume by Region (2027-2032)
- 4.3.2 Global Edaravone Sales in Value by Region (2027-2032)
- 4.3.3 Global Edaravone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Edaravone by Application
- 5.1 Edaravone Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Edaravone Market Size by Application
- 5.2.1 Global Edaravone Market Size Overview by Application (2021-2032)
- 5.2.2 Global Edaravone Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Edaravone Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Edaravone Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Edaravone Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Edaravone Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Edaravone Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Edaravone Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Mitsubishi Tanabe Pharma
- 6.1.1 Mitsubishi Tanabe Pharma Company Information
- 6.1.2 Mitsubishi Tanabe Pharma Business Overview
- 6.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Mitsubishi Tanabe Pharma Edaravone Product Portfolio
- 6.1.5 Mitsubishi Tanabe Pharma Recent Developments
- 6.2 Piramal Healthcare
- 6.2.1 Piramal Healthcare Company Information
- 6.2.2 Piramal Healthcare Business Overview
- 6.2.3 Piramal Healthcare Edaravone Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Piramal Healthcare Edaravone Product Portfolio
- 6.2.5 Piramal Healthcare Recent Developments
- 6.3 Simcere
- 6.3.1 Simcere Company Information
- 6.3.2 Simcere Business Overview
- 6.3.3 Simcere Edaravone Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Simcere Edaravone Product Portfolio
- 6.3.5 Simcere Recent Developments
- 6.4 Sun Pharmaceutical Industries Ltd.
- 6.4.1 Sun Pharmaceutical Industries Ltd. Company Information
- 6.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 6.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio
- 6.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 6.5 Taj Pharmaceuticals Ltd.
- 6.5.1 Taj Pharmaceuticals Ltd. Company Information
- 6.5.2 Taj Pharmaceuticals Ltd. Business Overview
- 6.5.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Taj Pharmaceuticals Ltd. Edaravone Product Portfolio
- 6.5.5 Taj Pharmaceuticals Ltd. Recent Developments
- 6.6 UCB India Ltd
- 6.6.1 UCB India Ltd Company Information
- 6.6.2 UCB India Ltd Business Overview
- 6.6.3 UCB India Ltd Edaravone Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 UCB India Ltd Edaravone Product Portfolio
- 6.6.5 UCB India Ltd Recent Developments
- 6.7 Unichem Laboratories Ltd
- 6.7.1 Unichem Laboratories Ltd Company Information
- 6.7.2 Unichem Laboratories Ltd Business Overview
- 6.7.3 Unichem Laboratories Ltd Edaravone Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Unichem Laboratories Ltd Edaravone Product Portfolio
- 6.7.5 Unichem Laboratories Ltd Recent Developments
7 North America by Country
- 7.1 North America Edaravone Sales by Country
- 7.1.1 North America Edaravone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Edaravone Sales by Country (2021-2026)
- 7.1.3 North America Edaravone Sales Forecast by Country (2027-2032)
- 7.2 North America Edaravone Market Size by Country
- 7.2.1 North America Edaravone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Edaravone Market Size by Country (2021-2026)
- 7.2.3 North America Edaravone Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Edaravone Sales by Country
- 8.1.1 Europe Edaravone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Edaravone Sales by Country (2021-2026)
- 8.1.3 Europe Edaravone Sales Forecast by Country (2027-2032)
- 8.2 Europe Edaravone Market Size by Country
- 8.2.1 Europe Edaravone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Edaravone Market Size by Country (2021-2026)
- 8.2.3 Europe Edaravone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Edaravone Sales by Country
- 9.1.1 Asia-Pacific Edaravone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Edaravone Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Edaravone Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Edaravone Market Size by Country
- 9.2.1 Asia-Pacific Edaravone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Edaravone Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Edaravone Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Edaravone Sales by Country
- 10.1.1 South America Edaravone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Edaravone Sales by Country (2021-2026)
- 10.1.3 South America Edaravone Sales Forecast by Country (2027-2032)
- 10.2 South America Edaravone Market Size by Country
- 10.2.1 South America Edaravone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Edaravone Market Size by Country (2021-2026)
- 10.2.3 South America Edaravone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Edaravone Sales by Country
- 11.1.1 Middle East and Africa Edaravone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Edaravone Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Edaravone Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Edaravone Market Size by Country
- 11.2.1 Middle East and Africa Edaravone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Edaravone Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Edaravone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Edaravone Value Chain Analysis
- 12.1.1 Edaravone Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Edaravone Production Mode & Process
- 12.2 Edaravone Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Edaravone Distributors
- 12.2.3 Edaravone Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst